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Abstract
Background: Alveolar volume measured according to the American Thoracic Society-European
Respiratory Society (ATS-ERS) guidelines during the single breath diffusion test can be
underestimated when there is maldistribution of ventilation. Therefore, the alveolar volume
calculated by taking into account the ATS-ERS guidelines was compared to the alveolar volume
measured from sequentiallly collected samples of the expired volume in two groups of individuals:
COPD patients and healthy individuals. The aim of this study was to investigate the effects of the
maldistribution of ventilation on the real estimate of alveolar volume and to evaluate some
indicators suggestive of the presence of maldistribution of ventilation.
Methods: Thirty healthy individuals and fifty patients with moderate-severe COPD were studied.
The alveolar volume was measured either according to the ATS-ERS guidelines or considering the
whole expired volume subdivided into five quintiles. An index reflecting the non-uniformity of the
distribution of ventilation was then derived (DeltaVA/VE).
Results: Significant differences were found when comparing the two measurements and the
alveolar volume by quintiles appeared to have increased progressively towards residual volume in
healthy individuals and much more in COPD patients. Therefore, DeltaVA/VE resulted in an
abnormal increase in COPD.
Conclusion: The results of our study suggest that the alveolar volume during the single breath
diffusion test should be measured through the collection of a sample of expired volume which could
be more representative of the overall gas composition, especially in the presence of uneven
distribution of ventilation. Further studies aimed at clarifying the final effects of this way of
calculating the alveolar volume on the measure of DLCO are needed. DeltaVA/VE is an index that
can help assess the severity of inhomogeneity in COPD patients.
Background
There is evidence that the gases inspired into the alveolar
regions are not well mixed and that the alveolar units fill
and empty sequentially [1-4]. Importantly, in the pres-
ence of prevalent lung diseases such as COPD, this process
may be exaggerated because of the increased time con-
stant of lung units [5,6]. As a matter of fact, when airways
are narrowed by inflammatory cells and mucus, the distri-
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bution of the inspired gas in the alveoli becomes progres-
sively impaired. This may result in marked differences in
gas composition within the lungs, as well as in inhomoge-
neous patterns of filling and emptying [7,8]. The different
profile of emptying and filling of the lung units causes dis-
crepancy in their gas tracer composition, thus creating
regional differences within lung units for tracer inert
insoluble gases such as helium or methane [9,10]. Indeed,
if there is unevenness in the distribution of a single inspi-
ration in the dilution of the tracer gas and incomplete
equilibration within respiratory units, as in the presence
of airflow obstruction, the pattern of reappearance of that
gas in a single expiration to residual volume will be con-
sequently influenced [11,12]. This may account for the
extreme difficulty in obtaining a sample that is represent-
ative of the overall gas composition using the most com-
mon laboratory tests [13].
It is well recognized that the single breath diffusion test
[14-16] requires a measurement of the alveolar volume.
According to recent ATS-ERS guidelines, such volume is
based on the sampling of 750–1000 ml of expired volume
after washout of the dead spaces when the tracer gases,
such as helium or methane, are promptly inhaled and
expected to be diluted in well-ventilated units during the
manoeuvre of inspiratory vital capacity in the course of
the test [17,18]. Whenever severe airflow occurs, the gas
mixes less effectively and, therefore, sampling in the ini-
tial expired concentration of the gas tracer is not always
correct as it is likely to overestimate the real value of alve-
olar gas concentrations and consequently underestimate
that of the alveolar volume. This discrepancy could lead to
substantial differences when calculating DLCO in COPD
patients [17,19].
We hypothesize that the alveolar volume measured
according to the ATS-ERS method is very different from
that calculated considering subsequent phases of the
expired volume in those areas where the gas composition
is different owing to the fact that the slow-emptying units
predominate. In the course of the single breath diffusion
test, with the aid of rapid response analyzers it is now pos-
sible to follow exhalation to the residual volume after
breath-hold and to measure in selected points of the exha-
lation process the instantaneous expired inert gas frac-
tions which could enter into the calculations of the
alveolar volume. In this way, we compared the measure-
ments of the standard alveolar volume obtained follow-
ing the ATS-ERS recommendations (VAst) to those
derived by considering the whole expirate of the same sin-
gle breath diffusion test, minus the dead spaces, divided
into five quintiles and considering the related expired
inert gas fractions (VAq) in each quintile. This procedure
allowed us to evaluate whether there existed any large dis-
crepancy between the two measurements of the alveolar
volume in those cases like COPD, where the process of
sequential emptying of different alveolar regions may be
excessive. This comparison was made both in healthy
individuals and in COPD patients.
Methods
The study included 30 healthy individuals and 50 patients
affected by COPD. The healthy subjects had no history of
smoking, nor respiratory symptoms consistent with the
diagnosis of COPD nor other pulmonary disease. The
healthy subjects were receiving no respiratory medication
nor any other medication which could affect the respira-
tory function. The patients with COPD fulfilled the diag-
nostic criteria of the Global Initiative for Chronic
Obstructive Lung Disease guidelines [20]. All patients
with COPD were smokers and were recruited from the
pulmonary disease unit of our Institution. At the time of
the study all patients with COPD were stable. Before the
testing session, all subjects were asked to withhold taking
inhaled short-acting β-agonist and/or anticholinergic
agents. Patients had no other cardiopulmonary disease,
and had experienced no upper respiratory tract infection
during the previous 4 weeks. Patients with COPD were
classified according to the results of spirometry as having
a moderate to severe obstruction. Informed written con-
sent was obtained for the study protocol according to the
policy of our Internal Review Board. Spirometry was per-
formed as stated by the ATS-ERS recommendations [21].
Airflow limitation was characterized by FEV1 and FEV1/VC
respectively below 70% and 88% of the normal value pre-
dicted after inhalation of a bronchodilator. Bronchodila-
tor reversibility was defined as an increase of 12% of the
baseline value and 200 mL respectively for either FEV1 or
FVC above the prebronchodilator baseline, 30 minutes
after inhalation of 400 µg of salbutamol [22]. All values
were expressed as percentage of reference values [23]. In
order to assess the pulmonary function, we measured
static lung volumes which were expressed as percentage of
reference values [23]. The single breath diffusing capacity
for carbon monoxide was determined using a fully com-
puterized spirometric system (Comprehensive Pulmonary
Laboratories Collins Medical Ferraris, USA-England)
which was the same instrument employed for spirometry
and lung volumes. The test was performed at sea level. The
system was equipped with rapid infrared analyzer devices
for carbon monoxide (CO) and methane (CH4). This gas
analyser system provided continuous tracings of CO and
tracer gas concentration during the test. DLCO was meas-
ured according to the ATS-ERS guidelines [16-18]. Each
subject performed the single breath CO test in sitting posi-
tion. The patients who were current smokers stopped
smoking at least 24 hours before the tests. The interval
between tests was only 4 minutes for healthy individuals
and over 10 minutes for severe COPD patients, according
to the ATS-ERS guidelines. The measured DLCO wasBMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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adjusted for hemoglobin concentration. The alveolar vol-
ume was measured by dilution in the lung of 0.3% of CH4
present in the inspiratory bolus of the breath test, in the
course of inspiratory vital capacity. The remainder of the
test gas mixture included 0.3% of CO, 21% of oxygen and
balance nitrogen.
In accordance with the purpose of this study the effective
alveolar volume was calculated by two different methods.
The first method directly measures tracer gas reduction
during breath-holding time according to the ATS-ERS
guidelines and was defined VAst (standard alveolar vol-
ume) obtained following the ERS-ATS recommendations
according to the following formula:
VAst = [FICH4/FACH4(750 mL)] × [Vinsp - (Vd instru-
mental + VD anat)]
where FICH4 = methane concentration in the inspired
gas, and FACH4 (750 mL) = methane concentration in the
alveolar sample collected for 750 mL after having dis-
carded the instrumental and anatomical dead spaces;
Vinsp = inhaled volume; VD = instrumental dead space
and VD anat = anatomical dead space. Sampling of the
tracer gas CH4 was executed at the mouth level of the
patient in real time and in correspondence of the meas-
urement of the inspiratory and mean expiratory volumes.
The second method, which allowed us to derive the alve-
olar volume subdividing the whole expirate into quintiles
(VAq), uses measurements made during the same
manoeuver. The difference is that the total expired space
is divided into quintiles. In these quintiles the mean con-
centrations of CH4 were promptly read and retained for
the calculations during exhalation from TLC to RV,
according to the following formula:
VAq = [(FICH4/FACH4(quintile)) × (Vinsp)] where:
FACH4 (quintile) = the methane concentration in the
expired volume of that quintile; Vinsp = inhaled volume.
Two examples of the different ways of deriving the alveo-
lar volume from the single breath CO manoeuver have
been reported in Figure 1. From the analysis of VAq (alve-
olar volume measured according to the method of subdi-
viding the whole expirate into quintiles) in our sample we
derived a parameter, defined as DeltaVA/VE, which repre-
sents the changes in percentage of the alveolar volume for
each litre of expired volume exhaled. This parameter was
compared between healthy individuals and COPD
patients.
Statistical analysis
Group data are expressed as mean and standard deviation.
The groups and functional parameters in Table 1 were
compared by the unpaired Student t-test. The mean values
of VAst (standard alveolar volume obtained following the
ERS-ATS recommendations) and VAq (alveolar volume
measured according to the method of subdividing the
whole expirate into quintiles) of two consecutive tests
were compared by the paired Student t-test to assess their
statistical differences. Differences in mean VAst and VAq
between two consecutive tests and their respective coeffi-
cients of repeatibility (defined as 2.77 × SD) were derived
from healthy subjects and patients with COPD using the
Bland Altman method [24]. Fisher's variance test was used
Typical tracings of CO and CH4 during exhalation of the single breath-hold CO test Figure 1
Typical tracings of CO and CH4 during exhalation of the single breath-hold CO test. An example of the standard method used 
to derive the alveolar volume during exhalation after the dead spaces have been entirely washed is reported for a healthy sub-
ject (left). This sample, which corresponds to the end of the knee on the CH4 and CO tracings after the hold time, usually 
measures between 500 and 1000 ml. An example of the method used to calculate the alveolar volume during exhalation subdi-
viding the whole expirate into five sized quintiles in a COPD patient is reported (right). The increased slope of CO and CH4 
tracings during the emptying phase when compared with the normal subject on the left is caused by the increased time-con-
stant of emptying of lung units.BMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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to compare the repeatibilities between groups at each VAq
and VAst and the level of significance was reported in
Table 2. Frequency distribution of changes in percentage
of DeltaVA/VE for each litre of expired volume exhaled
was employed in our two samples and was graphed as
box-wisker plot diagram where the horizontal lines in the
box represent the 50th percentile median, the borders of
the box the 25th and 75th percentiles of distribution and
the wiskers the 10th and 90th percentiles.
Results
Subjects' characteristics
Demographic characteristics and parameters of lung func-
tion in healthy subjects and COPD patients have been
reported in Table 1. Our COPD patients were different
only in terms of height when compared to healthy indi-
viduals who had a history of smoking; males were more
present in the COPD group when compared to healthy
individuals (92% vs 47% respectively) and only 8% of 50
Table 1: Demographic and functional characteristics of the study population
"Healthy" individuals (n = 30) COPD patients (n = 50) Significance
Age years 65 ± 6 68 ± 6 ns
Weight Kg 71 ± 10.48 75 ± 12.53 ns
Height cm 162 ± 9.58 168 ± 6.44 p < .0038
BMI Kg/m2 27 ± 4 27 ± 6 ns
Pack-years n 0 43.4 ± 17.5 NA*
Males % 47 92 NA*
Hemoglobin g/dl 13.97 ± 1.07 14.55 ± 1.07 p < .02
FVC %pred 120 ± 13 84 ± 17 p < .0001
FEV1 %pred 116 ± 15 45 ± 12 p < .0001
FEV1/VC %pred 97 ± 7 53 ± 13 p < .0001
VC %pred 119 ± 13 87 ± 16 p < .0001
RV %pred 102 ± 22 145 ± 37 p < .0001
TLC %pred 106 ± 11 106 ± 14 ns
RV/TLC %pred 95 ± 15 131 ± 22 p < .0001
DLCO %pred 95 ± 17 64 ± 22 p < .0001
VA %pred 93 ± 10 80 ± 13 p < .0001
DL/VA %pred 97 ± 14 71 ± 26 p < .0001
Demographic and functional characteristics of the study population.
Data are expressed as mean ± standard deviation. Significant differences appear at the 0.05 level.
Abbreviations and references for the predicted formulas of each variable can be seen in the text. * Not applicable
Table 2: Coefficients of repeatability (defined as 2.77 × SD) for VAst (standardalveolar volume obtained following the ERS-ATS 
recommendations) and VAq (alveolar volume measured according to the method of subdividing the wholeexpirate into quintiles) 
between two consecutive tests for healthy individuals and patients with COPD using the method of Bland-Altman (24) and comparison 
of the repeatibilities between groups (healthy individuals and COPD patients)
Healthy individuals (n = 30) COPD patients (n = 50)
°p < *p < **p <
VAst ± 144 ml .073 ± 165 ml .011 .753
VAq (first) ± 78 ml .481 ± 58 ml .198 .999
VAq (2nd) ± 71 ml .745 ± 86 ml .022 .843
VAq (3rd) ± 80 ml .825 ± 129 ml .161 .992
VAq(4th) ± 95 ml .356 ± 78 ml .256 .149
VAq (5th) ± 80 ml .740 ± 94 ml .507 .787
Coefficients of repeatability (defined as 2.77 × SD) for VAst (standard alveolar volume obtained following the ERS-ATS recommendations) and VAq 
(alveolar volume measured according to the method of subdividing the whole expirate into quintiles) for healthy individuals and patients with COPD 
using the Bland-Altman method (24), in order to examine the variation between two consecutive tests. The level of statistical significance in terms of 
probability (p) has been reported. It is evident that the variation in the calculated alveolar volume between two tests appeared statistically significant 
for the VAst of COPD patients. In the healthy individuals it resulted approximately close to the level of significance. On the contrary, for the alveolar 
volumes calculated by the quintile method, the variation between two consecutive tests was only significant in the 2nd quintile of the COPD patients. 
In addition, no differences were observed in the comparison in repeatibilities between groups at each VAq (and VAst).
level of significance related to the comparison between coefficients of repeatibilities within two measurements for healthy individuals (°p < ) and 
COPD patients (*p < );
level of significance of the repeatibilities by the analysis of variance between groups (healthy individuals and COPD patients) (** p < )BMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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COPD patients were females, whereas the control group
was close to half female, indicating a disproportion
between males and females in this cohort of patients and
control group which surely indicates a gender difference
in terms of smoking habit. Functional parameters showed
signs of severe airflow obstruction and of hyperinflation
in COPD patients. DLCO single breath was significantly
reduced in COPD patients, as well as its ratio to alveolar
volume. With regard to patient performance of the single
breath test, 3 healthy individuals and 7 COPD patients
were discarded because their inspiratory time during the
manoeuver was over 4 seconds, while 9 healthy subjects
and 34 COPD patients were discarded because their
breath-hold time was too long. The dead space washout
volumes (including instrumental, filtering and anatomic
dead space) resulted 563 ± 134 ml (range 150–750 ml)
and 447 ± 134 (range 340–750 ml) respectively in nor-
mals and in patients with COPD. The sample collection
volumes were 561 ± 195 ml (range 240–920 ml) and 490
± 140 ml (range 240–880 ml) respectively in healthy indi-
viduals and in patients with COPD.
Calculated alveolar volume, choice of quintiles and 
repeatibility between tests
The ideal approach would be to compute automatically,
point by point, as a continuum, the FICH4/FECH4 ratio
during the whole expiration in the course of the single-
breath CO test. In order to evaluate whether the sampling
of five quintiles was sufficient, we subdivided the whole
expired volume into a series of four, five, six and ten exact
portions. The alveolar volume calculated using four por-
tions was significantly different when compared to that
obtained using five, six or ten portions in both healthy
individuals and in COPD patients. At the same time, no
differences were observed when the calculated alveolar
volumes, obtained subdividing the whole expirate into six
portions, were compared to five or ten exact portions both
in healthy individuals and in COPD patients. As a result
of this prior analysis, the method of sampling five quin-
tiles appeared sufficiently good, more precise than the use
of four portions, not different from the use of six or ten
portions. Therefore, the method was considered suitable
for the purpose of our study and was ultimately chosen
and compared to the ERS-ATS method of measuring the
alveolar volume.
The repeatability of VAst (standard alveolar volume
obtained following the ERS-ATS recommendations) and
of VAq (alveolar volume measured according to the
method of subdividing the whole expirate into quintiles)
was tested both in healthy individuals and in patients
with COPD and has been reported in Table 2.
It is evident that variation in the calculated alveolar vol-
ume between two tests appeared statistically significant
for the VAst of COPD patients. In the healthy individuals
it resulted approximately close to the level of significance.
On the contrary, for the alveolar volume calculated by the
quintile method, the variation was only statistically signif-
icant for the 2nd quintile of the COPD patients. No other
significant variations were observed in the healthy indi-
viduals nor in the other quintiles of the COPD patients. In
addition, the healthy individuals and COPD patients were
not different in repeatability (Table 2).
The results of the comparison between the two ways of
measuring the alveolar volume have been reported in Fig-
ures 2 and 3, for healthy individuals and COPD patients
respectively. In the healthy individuals the values of the
alveolar volume were not significantly different between
the two methods of assessment in the first 20 and 40% of
exhaled volume. Significant differences were instead
detected in the following portions of expired volume
when exhaled to residual volume. In the patients with air-
flow obstruction there were remarkable differences
between the two methods of measuring the alveolar vol-
ume at the beginning of exhalation and were present
throughout the emptying phase to residual volume. The
alveolar volume measured in the last quintile appeared
significantly greater than that measured in the previous
Graphic representation of the alveolar volume calculated by  the two methods in healthy individuals Figure 2
Graphic representation of the alveolar volume calculated by 
the two methods in healthy individuals. The bars represent 
the mean values and the lines above the bars represent one 
standard deviation from the mean values. The alveolar vol-
ume calculated by the quintile method appears significantly 
different from that calculated by the ERS-ATS standard (the 
left hand image is taken from reference 18) from the third 
quintile, corresponding to 40% of exhaled volume, to residual 
volume (RV) from total lung capacity (TLC).BMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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quintiles, thus suggesting an effect related to the sequen-
tial emptying of lung units. As reported in Figure 4, it is
evident that the alveolar volume does not exhibit any
remarkable changes when related to the expired volume
in healthy individuals at variance with those of the COPD
patients. This result suggests a progressive increase of alve-
olar volume along with the process of emptying of the
lung units in patients with disease.
The frequency distribution of DeltaVA/VE (changes in
percentage of the alveolar volume for each litre of expired
volume exhaled) at different lung volumes was compared
between healthy individuals and COPD patients in the
box-plot graph of Figure 5. Ninety percent of COPD
patients showed a progressive increase of the alveolar vol-
ume along with exhalation which was approximately
more than 20% with respect to normals. Thus, it appears
that the changes of alveolar volume during exhalation are
quite relevant in COPD patients and that uneven empty-
ing is necessary for these results, but not sufficient; uneven
dilution ratios are also necessary.
Discussion
The main findings of this study are as follows: 1. the meas-
ure of the alveolar volume is different depending on the
point where sampling for evaluation of the alveolar con-
centration of inert tracer gas methane is done in the course
of exhalation of the single breath diffusion test; 2. the
alveolar volume measured by the quintile method shows
a progressive increase from total lung capacity to residual
volume and appears significantly different when com-
pared with that measured according to the ATS-ERS guide-
lines; 3. its size increases much more in COPD patients
than in healthy individuals from the beginning to the end
Graphic representation of the relation between the mean  values of alveolar volume, calculated by the quintile method,  and those of the corresponding DLCO, in healthy individuals  (panel A) and in COPD patients (panel B), at different  expired volumes Figure 4
Graphic representation of the relation between the mean 
values of alveolar volume, calculated by the quintile method, 
and those of the corresponding DLCO, in healthy individuals 
(panel A) and in COPD patients (panel B), at different 
expired volumes. The alveolar volume does not show any 
remarkable change when related to the expired volume in 
healthy individuals (only 300 ml), at variance with those of 
COPD patients. In addition, DLCO decreases by 1.5 mmol/
min/mmHg with respect to the slight changes of the alveolar 
volume in healthy individuals, whereas it increases by less 
than 1 mmol/min/mmHg for a total increase of 2.5 litres of 
alveolar volume in COPD patients from TLC to RV.
Graphic representation of the alveolar volume calculated by  the two methods in COPD patients Figure 3
Graphic representation of the alveolar volume calculated by 
the two methods in COPD patients. The bars represent the 
mean values and the lines above the bars represent one 
standard deviation from the mean values. The alveolar vol-
ume calculated by the quintile method appears significantly 
different from that calculated using the standard method for 
all quintiles, except for the second one. It is evident that the 
alveolar volume, measured on the instantaneous CH4 frac-
tion of each quintile, progressively increases from the begin-
ning to the end of exhalation from total lung capacity (TLC) 
to residual volume (RV).BMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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of the exhalation; 4. changes of the mean alveolar volume
per litre of the expired volume exhaled, expressed as Del-
taVA/VE, are significantly and remarkably greater in
COPD patients with severe airflow obstruction than in
healthy individuals; 5. DeltaVA/VE represents a parameter
that is influenced by the effect of non-uniform distribu-
tion of convective ventilation as well as by the increased
time-constants of the emptying of lung units in diseased
lungs.
It is well documented that the single breath diffusion test
may markedly increase or slightly change upon the effect
of variation in lung volume [14,15,25-29].
Although this study did not provide any conclusive infor-
mation on how the final DLCO can be affected by the
changes of lung volume as well as by size and precise esti-
mate of the alveolar volume, in our COPD patients it
seems to increase on the average by 1 mmol/min/mmHg
for a total increase of 2.5 litres of alveolar volume, as
reported in Figure 4. A different type of behaviour was
observed in the healthy individuals who showed values of
DLCO that decreased by 1.5 mmol/min/mmhg when
compared to the slight changes of the alveolar volumes.
The purpose of our study was to indicate the weakness of
the ATS-ERS method to measure the alveolar volume,
which collects the alveolar inert gas concentration at the
beginning of exhalation, especially in diseased lungs. In
fact at this exact point (on the average a volume of 750
ml) the concentration of the tracer gas is not representa-
tive of the mean alveolar gas concentration and thus of the
real alveolar volume, since it represents only the behav-
iour of the faster lung units [11,17]. This feature is remark-
able in patients with severe airflow obstruction and is less
evident in healthy individuals [30]. We could argue that in
subjects like our healthy individuals, who are non smok-
ers, and whose lungs have a near-normal distribution of
ventilation, sampling of the alveolar inert gas CH4 at the
beginning of exhalation does not appear much influenced
by the effect of differences in the physiological regional
dilution during inhalation of the test gas [7,31]. Instead,
in the case of our patients affected by airflow obstruction
and with signs of hyperinflation of their lungs, extreme
non-uniformity of ventilation may predominate.
Literature well documents the extent to which the distri-
bution of ventilation becomes progressively more inho-
mogeneous at high lung volume [32] or under the effect
of modifications in tidal volumes, flows, posture and in
the presence of asymmetrical geometry of lung units as
well as in normal lungs [31,33]. In this study, no striking
differences were detected when all healthy individuals
and COPD patients were reclassified according to their
significantly higher or lower expired flows and conse-
quently tested to search any relations with the calculated
alveolar volumes. This analysis showed only a slight
increase of VAst (standard alveolar volume obtained fol-
lowing the ATS-ERS recommendations) when it was asso-
ciated with a higher flow, not exhibited by the calculated
VAq (alveolar volume measured according to the method
of subdividing the whole expirate into quintiles). This
result indicates that VAst (standard alveolar volume
obtained following the ATS-ERS recommendations) is
more sensitive to the different profile of emptying of alve-
oli when compared to the method of quintiles, which
always takes into account its standardization for the
whole expired volume of the subject (which is 20% of the
whole expirate).
The exaggerated asymmetry of lung units caused by the
obstructive airway diseases may ultimately be responsible
for the inequality of gas concentration within alveolar gas
and, therefore, for the very inhomogeneous dilution of
the concentration of the tracer gas methane in the course
of the single breath CO inhalation test.
In 1978 Ferris et al.[34] compared the single breath
helium dilution alveolar volume and a 7-min rebreathing
helium alveolar volume in normals and in COPD
Box-wisker plots of the percentage changes of VA per litre of  expired volume (Delta VA/VE) in healthy individuals and in  COPD patients Figure 5
Box-wisker plots of the percentage changes of VA per litre of 
expired volume (Delta VA/VE) in healthy individuals and in 
COPD patients. The horizontal lines represent the 50th per-
centile (median); limits of boxes are the 25th and 75th per-
centiles; the wiskers are the 10th and 90th percentiles. More 
than 90% of patients with COPD showed significant changes 
in alveolar volume when sampled at different intervals of lung 
volume. This suggests a different time constant of lung units 
coupled with a non-homogeneous distribution of ventilation.BMC Pulmonary Medicine 2007, 7:18 http://www.biomedcentral.com/1471-2466/7/18
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patients, and found that the alveolar volume measured
according to the two different methods did not underesti-
mate DLCO in the population of normals except for those
patients with severe airflow obstruction. In conclusion,
the authors suggested that the single breath method may
be adequate for normals, but not for COPD, since the var-
iations and fluctuations in the alveolar gas concentrations
during exhalation are responsible for an incorrect esti-
mate of the alveolar volume. This led the authors to con-
clude that more accurate methods for the alveolar volume
were required [17,35].
Some explanations for the remarkable differences in the
values of the alveolar volume when measured at the dif-
ferent intervals of exhalation are well reported in the
paper by Yuh T Huang et al.[36]. These authors provided
strong evidence in the evaluation of the volume-depend-
ent distribution of DLCO in normals at rest and during
exercise; they showed that the intrabreath DLCO during
single exhalation in the healthy subjects was non linear
and could be described by a polynomial model. The two
explanations for such behaviour seem to be in accordance
with the results found in our study: one explanation
entails the sequential emptying profile of the lung (i.e. the
" first in-last out phenomenon") which accounts for the
difference in the contribution of alveolar gas concentra-
tion. Indeed, it is well known that the gas sampled at
higher lung volume generally reflects the contribution
from the lower part of the lung and of the faster units,
which empty earlier and probably have a different
regional concentration of tracer gas. The other explana-
tion may reside in the time-constants of the lung units,
which are increased in diseased lungs. As a matter of fact,
by looking at the methane profile during exhalation of a
COPD patient (Figure 1, right side) its steeper decreasing
slope from TLC to RV is evident. This increase may prima-
rily suggest that the recovery of the concentration of the
inhaled inert gas is progressively diminishing towards
residual volume, which may result in an increased time
constant of lung units. The heterogeneous profile of inert
gas methane during exhalation, amplified in COPD, is
ultimately responsible for the differences in the calcula-
tions of the alveolar volume and it allowed us to derive
the index named DeltaVA/VE (changes in percentage of
the alveolar volume for each litre of expired volume
exhaled), which seems to reflect the effect of the phenom-
ena described above. In fact, this index DeltaVA/VE, as
direct expression of the non-uniform distribution of ven-
tilation, resulted significantly higher – in quantitative
terms – in COPD than in healthy individuals (Figure 5).
As a matter of fact, we propose this index as a very rapid,
non invasive and simple tool that can be obtained rou-
tinely in patients to help the pulmonologists evaluate the
effect of inhomogeneity of ventilation in the course of the
single breath-hold test. Finally, the changes of the alveolar
volume from TLC to RV measured by quintiles were 0.110
litres in the healthy individuals, 1.332 litres in COPD
patients (Figures 2 and 3). Instead, when we use the ATS-
ERS method to compare the alveolar volume with that
derived from the average of the alveolar volume measured
in each quintile we find similarity in healthy individuals
(VAst 5.10 ± 1.33 litres vs VAq 5.15 ± 1.34 litres, p = ns)
but significant differences, as expected, in COPD patients
(VAst 4.98 ± 1.04 vs VAq 5.36 ± 1.57 litres, p < 0.0001).
It follows that the true mean alveolar volume should be
that derived from the average of each alveolar volume
exhaled in each quintile (Figures 2, 3).
Conclusion
In summary, our study provides additional information
on the real estimate of the alveolar volume when different
sampling points are used in the course of the single breath
diffusion test for the assessment of diffusing capacity. A
model was developed which subdivided into 5 parts the
total volume of air exhaled after the breath-hold manoeu-
ver was developed. The instantaneous concentration of
tracer gas methane was considered in each quintile; the
calculation of the alveolar volume was consequently
derived and compared with that derived from the tradi-
tional method according to the ATS-ERS recommenda-
tions. A significant difference was found between these
two ways of measuring the alveolar volume, and the
results showed significant differences in COPD patients.
The conclusion drawn is that sampling at the beginning of
exhalation of the single breath-test is not representative of
the real mean alveolar gas concentration, especially when
an important ventilation/perfusion mismatch is present.
A non-uniform distribution of ventilation, coupled with
an exaggerated time constant of emptying of lung units,
seems ultimately to be the mechanism responsible for the
differences in the size of the alveolar volume when meas-
ured differently in the course of expiration. An index
reflecting this process was identified which appeared use-
ful to assess the degree of non-uniformity of the ventila-
tion distribution. These analyses provide a basis for
further study in order to test the effects on DLCO of this
way of measuring the alveolar volume from the sampling
of the instantaneous tracer gas concentrations at different
intervals of exhalation, but also to observe the behaviour
of the diffusivity of carbon monoxide at different intervals
of exhalation, as a direct consequence of the complex
emptying process of lung units in different diseased states.
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